Home Sun Care A Q&A on the Mounjaro-Like Weight Loss Drug

A Q&A on the Mounjaro-Like Weight Loss Drug

0
A Q&A on the Mounjaro-Like Weight Loss Drug

[ad_1]

The approval by the U.S. Meals and Drug Administration (FDA) of the load loss drug Zepbound (tirzepatide) will give thousands and thousands of People with chubby and weight problems a robust new possibility for shedding extra kilos.

Zepbound, a once-weekly injected medication with the identical lively ingredient as the favored kind 2 diabetes drug Mounjaro, was cleared by the FDA for power weight administration by adults with weight problems, and by adults with chubby plus a minimum of one weight-related well being situation resembling hypertension, kind 2 diabetes, or elevated ldl cholesterol.

Tirzepatide, the lively ingredient in Zepbound and Mounjaro, is the primary drug in a brand new household of medicines that concentrate on two hormones — glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) — which are concerned in sustaining wholesome blood sugar ranges and sending alerts of satiety from the intestine to the mind.

In contrast, the kind 2 diabetes drug Ozempic and the load loss drug Wegovy each comprise a unique lively ingredient, semaglutide, that targets solely the hormone GLP-1.

[ad_2]

LEAVE A REPLY

Please enter your comment!
Please enter your name here